Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NV-A01 in Advanced Glioma
NCT06193538Phase 1Recruiting
- Sponsor
- Yejishan Hospital of Wannan Medical College
- Start
- Sep 2023
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of NV-A01 in glioblastoma (GBM), sponsored by Yejishan Hospital of Wannan Medical College. Primary endpoint: Frequency of Grade 3 or Above Adverse Events at 1 month. Started Sep 2023; status: recruiting.
02
Drugs
NV-A01
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT06193538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06193538.